TMAC Outsourced Opportunity.

Territory coverage: N.CA, OR, WA, ID, WY, MT, AK

Serving as a field-based extension of Medical Affairs, the Medical Science Liaison (MSL) will represent a clinical-stage immuno-oncology company that is focused on the discovery and development of therapies that engage the body's immune system to fight cancer. The MSL will initially support Company's anti-PD-1 product candidate, which has received Fast Track designation from the FDA for investigation in combination with Company's anti-CTLA-4 product candidate, for the treatment of patients with locally advanced, relapsed or refractory metastatic cervical cancer. MSL will also support Company's robust pipeline discussions and the individual products as programs mature.

The MSL will facilitate and coordinate the execution of Company’s corporate, scientific, and clinical strategies with these thought leaders within academic, clinical, and healthcare organizations. The execution of these strategies will rely on robust scientific exchanges in support of, and/or for the expansion of current understanding of therapeutic concepts, as well as to ensure the safe and effective utilization of Company’s products when appropriate.

Duties and Responsibilities:

• Establish Company as a leading company committed to immuno-oncology discovery and development of therapies that engage the body's immune system to fight cancer and infections.
• Maintain clinical, scientific, and technical expertise in relevant Immuno-Oncology therapies and treatment areas.
• Collaborate with Company's Medical Affairs, Market Access, Clinical Development, Commercial and other relevant internal stakeholders, and serve as a resource to external stakeholders.
• Develop and track KOL engagement plans – identify, develop, and maintain long-term collaborative relationships with KOLs within assigned region.
• Participate in medical and scientific exchanges with the medical/scientific community.
• Support overall Medical Affairs strategy at Company, including Investigator-Sponsored Studies, Thought Leader Advisory Boards, National and Regional Educational efforts, Publications and attendance and coverage of Medical Conferences.

Qualifications:

• Advanced terminal degree required (PharmD, PhD or MD), or NP, MSN with GYN Oncology and MSL experience considered
• Minimum of 4 years previous oncology MSL experience required
• Minimum of 2 years of clinical or research experience in GYN Oncology preferred
• Established relationships with GYN Oncology KOL’s and stakeholders at both academic institutions and community practices
• Ability to travel, locally and regionally, up to 60% with overnight stays (e.g., KOL meetings, site locations, internal meetings, medical meetings and congresses, training)
• Experience working with payers of formulary committees strongly preferred
• Knowledge of FDA requirements and PhRMA Code, including regulations governing compliant scientific exchange